Land: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Iopamidol
Bracco Imaging spa
V08AB; V08AB04
Iopamidol
150 milligram(s)
Solution for injection
Product subject to prescription which may not be renewed (A)
Watersoluble, nephrotropic, low osmolar X-ray contrast media; iopamidol
Marketed
1986-11-19
PACKAGE LEAFLET: INFORMATION FOR THE USER NIOPAM 150 SOLUTION FOR INJECTION (Iopamidol) The name of your medicine is Niopam 150 solution for injection, which will be called Niopam throughout this leaflet. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet, see section 4 WHAT IS IN THIS LEAFLET : 1. What Niopam is and what it is used for 2. What you need to know before you are given Niopam 3. How you are given Niopam 4. Possible side effects 5. How to store Niopam 6. Contents of the pack and other information 1. WHAT IS NIOPAM AND WHAT IT IS USED FOR Niopam is a special dye (or contrast agent) which blocks X-rays because it contains iodine. Niopam works by helping your doctor to see the internal body structures on an X-ray picture. Your doctor has prescribed Niopam to help view the blood vessels using X-rays. This medicine is for diagnostic use only. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN NIOPAM YOU SHOULD NOT BE GIVEN NIOPAM IF YOU: • Are allergic to Iopamidol, or any other ingredients of this medicine (listed in Section 6) TAKE SPECIAL CARE WITH NIOPAM AND TELL YOUR DOCTOR IF YOU HAVE ANY OF THE FOLLOWING CONDITIONS: • A history of allergy or asthma • Diabetes • Heart problems • High blood pressure in the lungs • Kidney or liver problems • Over-active thyroid gland (this is particularly important in newborn babies) • A history of epilepsy • Myelomatosis (Cancer of the plasma cells in the blood) • Severe systemic disease (a disease affecting more than one part or organ of the body) • Blood clots, circulation problems, inflammation Lestu allt skjalið
Health Products Regulatory Authority 19 May 2021 CRN009ZF0 Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Niopam 150, Solution for Injection, glass bottles 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The solution contains 30.62 % w/v Iopamidol equivalent to 150 mg iodine/ml. Each ml contains 306.2 mg of Iopamidol. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. A clear, aqueous solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS This medicinal product is for diagnostic use only. X-ray contrast medium for injection, particularly in digital substraction angiography. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Method of administration In digital substraction angiography: Intraventricular Intra-arterial Posology Intra arterial injection: Adults: 1-40ml Children: 0.5 - 0.75 ml/kg Ventricular angiography: 1-1.5 ml/kg The dosage must be adapted to the examination, the age, body weight, cardiac output, renal function, general condition of the patient and the technique used. Usually the same iodine concentration and volume are used with other iodinated x-ray contrast in current use. As with all contrast media, the lowest dose necessary to obtain adequate visualisation should be used. Non ionic contrast media have less anti coagulant activity in vitro than ionic media. Meticulous attention should therefore be paid to angiographic technique. Non ionic media should not be allowed to remain in contact with blood in the syringe and intravascular catheters should be flushed frequently, to minimise the risk of clotting, which rarely has led to serious thromboembolic complications after procedures. Therefore, meticulous angiographic techniques are recommended including close attention to guide wire and catheter manipulation, use of manifold systems and/or three-way stopcocks, frequent catheter flushing with heparinized saline solutions, and minimizing the length of the procedure. As experience shows that warmed contrast media are better tolerate Lestu allt skjalið